Evidence map›Paper›PMID 40912726›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2025

Guidelines for diet-induced models of cardiometabolic syndrome.

Timothy M Sveeggen, Pooneh Bagher, Hiroe Toba, Merry L Lindsey, Rebecca H Ritchie, Verónica J Miksztowicz, Germán E González

Abstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Timothy M SveeggenDepartment of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, United States.ORCID 0000-0003-2120-2165
Pooneh BagherDepartment of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, United States.ORCID 0000-0002-9778-6200
Hiroe TobaLaboratory of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.ORCID 0000-0002-3860-805X
Merry L LindseyDepartment of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN and Research Service, Nashville VA Medical Center, Nashville, Tennessee, United States.ORCID 0000-0002-4090-0391
Rebecca H RitchieDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.ORCID 0000-0002-8610-0058
Verónica J MiksztowiczUniversidad de Buenos Aires, Facultad de Odontología, Cátedra de Bioquímica General y Bucal, Buenos Aires, Argentina.
Germán E GonzálezLaboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Instituto de Investigaciones Biomédicas (UCA-CONICET), Facultad de Ciencias Médicas, Universidad Católica Argentina, Buenos Aires, Argentina.ORCID 0000-0002-4433-9837

Funding

The role of hemoglobin alpha in diabetes-related vascular dysfunctionR01HL155618 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BAGHER, POONEH · 2021 to 2025
$2.5M
Short Course In Transferable Skills Training (SHIFT) ProgramR25GM151274 · NIGMS · MEHARRY MEDICAL COLLEGE · PI MERRY L. LINDSEY, Pius N Nde · 2023 to 2026
$1.9M
STrengthening Research OpportuNities for Growth at Meharry Medical College (Meharry-STRONG)UC2MD019626 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Taneisha Gillyard Cheairs, PANDU R GANGULA · 2024 to 2026
$1.1M
Development of Transgenic Mouse Model Resources for Red Fluorescence-Based Genetically Encoded Indicator StudiesR21OD037867 · OD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Pooneh Bagher, Channabasavaiah Gurumurthy · 2025 to 2026
$422k
Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (agenciaidiar) PICT 2018-03267Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (agenciaidiar) PICT 2019-02987American Heart Association (AHA) 25IVPHA1462290Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) PIP 938Department of Health, Australian Government MRF2023754Federal Government | DHAC | National Health and Medical Research Council (NHMRC) APP2029251HHS | National Institutes of Health (NIH) GM151274HHS | National Institutes of Health (NIH) R01HL155618HHS | National Institutes of Health (NIH) R21OD037867HHS | National Institutes of Health (NIH) UC2MD019626NHLBI NIH HHS R01 HL155618NIGMS NIH HHS R25 GM151274NIH HHS R21 OD037867NIMHD NIH HHS UC2 MD019626Takeda Science Foundation (TSF) 2022060878U.S. Department of Veterans Affairs (VA) I01CX002780
6 · The paper itself

Abstract

Cardiometabolic syndrome (CMS) encompasses a cluster of metabolic abnormalities, including obesity, insulin resistance, dyslipidemia, and hypertension, that collectively increase the risk of cardiovascular disease and type 2 diabetes. Animal models are widely used to study CMS, with diet-induced models being the most physiologically relevant. A lack of reporting standards and variability in dietary composition, feeding duration, and macronutrient content across studies hinder reproducibility assessment and translational impact evaluation. We provide standardized guidelines for the consideration, preparation, and use of diets in experimental models of CMS. Advantages and limitations of different diet-induced models are compared with genetic and pharmacological approaches, emphasizing replicability to human metabolic dysregulation. Key components include macronutrient composition, fat source selection, feeding duration, strain susceptibility, and sex differences. In addition, we outline husbandry practices, including environmental factors, bedding material, and enrichment conditions, which can affect metabolic outcomes. Standardization is essential for enhancing experimental reproducibility and facilitating cross-study comparisons. These guidelines serve as a framework for researchers to optimize dietary interventions in CMS models, improving the predictive value of preclinical findings for translational applications to aid in the development of targeted therapeutic strategies.

Indexed as

DietDisease Models, AnimalMetabolic SyndromeAnimalsHumansReproducibility of Resultscardiometabolic syndromecardiorenalhigh-fat diethusbandrynutrition

Identifiers

PMID40912726
PMCPMC12573438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.